COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE...

Hematological Oncology 2017 / 06 Vol. 35

COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY

Tam, C.S., Roberts, A.W., Anderson, M., Dawson, S., Hicks, R., Burbury, K., Turner, G., Di Iulio, J., Bressel, M., Westerman, D., Agarwal, R., Pott, C., Dreyling, M., Dawson, M., Seymour, J.F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_134
Date:
June, 2017
File:
PDF, 162 KB
english, 2017
Conversion to is in progress
Conversion to is failed